Immunologic benefits of maternal living donor allografts in pediatric liver transplantation: fewer rejection episodes and no evidence of de novo allosensitization.
Arianna BarbettaGlenda MeebergBrittany RocqueSarah BarhoumaCarly WeaverSusan GilmourFarah FaytrouniOrlee GuttmanShannon ZielsdorfKambiz EtesamiYong KwonGeorge YanniPatricia CampbellJames ShapiroJuliet A EmamaulleePublished in: Pediatric transplantation (2021)
These data support the concept of immunologic benefit of maternal-LLD in pediatric LT, with lower rates of rejection and allosensitization post-LT when compared to DDLT recipients.